Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Consolidated Statements Of Cash Flows [Abstract]
Net income	$ 316	$ 251
Adjustments to reconcile net loss to net cash from operating activities:
Provision for loan losses	50	75
Depreciation	53	52
Amortization, net	(8)	(6)
Net loss on sales of securities		12
Originations of loans held for sale	(2,936)	(12,123)
Proceeds from sale of loans held for sale	2,255	14,134
Net gains on sales of loans	(28)	(84)
Earnings on bank owned life insurance	(33)	(32)
Stock-based compensation expense	30	35
Change in deferred income taxes	(31)
Net change in:
Accrued interest receivable and other assets	939	362
Accrued interest payable and other liabilities	166	(135)
Net cash from operating activities	773	2,541
Available-for-sale securities:
Maturities, prepayments and calls	86	1,073
Loan originations and payments, net	(4,567)	(10,049)
Proceeds from the sale of loans	1,124
Additions to premises and equipment	(6)	(6)
Net cash used by investing activities	(3,363)	(8,982)
Cash flows from financing activities
Net change in deposits	1,964	2,415
Proceeds from FHLB advances		2,500
Repayments on FHLB advances		(2,500)
Net change in advances by borrowers for taxes and insurance	(303)	(100)
Cash dividends paid on Series B preferred stock	(187)	(187)
Net cash from financing activities	1,474	2,128
Net change in cash and cash equivalents	(1,116)	(4,313)
Beginning cash and cash equivalents	25,895	28,207
Ending cash and cash equivalents	24,779	23,894
Supplemental cash flow information:
Interest paid	687	578
Supplemental noncash disclosures:
Loans transferred from held for sale to portfolio		834
Dividends payable on Series B preferred stock	$ 187	$ 187